(Q51199021)

1 April 2018

title

Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease. (English)

1 reference

1 April 2018

author

Rukshana Shroff

7

1 reference

1 April 2018

Mandy Wan

object named as

Mandy Wan

1

0 references

Lesley Rees

6

object named as

Lesley Rees

1 reference

1 April 2018

author name string

Colette Smith

2

1 reference

1 April 2018

Vanita Shah

3

1 reference

1 April 2018

Ambrose Gullet

4

1 reference

1 April 2018

David Wells

5

1 reference

1 April 2018

language of work or name

English

0 references

publication date

23 November 2012

1 reference

1 April 2018

Nephrology Dialysis Transplantation

published in

1 reference

1 April 2018

volume

28

1 reference

1 April 2018

issue

1

1 reference

1 April 2018

page(s)

153-161

1 reference

1 April 2018

Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

Activated injectable vitamin D and hemodialysis survival: a historical cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

Chronic kidney disease and risk of major cardiovascular disease and non-vascular mortality: prospective population based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

Cardiovascular complications in children with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

Update on fibroblast growth factor 23 in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the "trade-off" hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

The phosphatonin fibroblast growth factor 23 links calcium-phosphate metabolism with left-ventricular dysfunction and atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

Elevated FGF 23 and phosphorus are associated with coronary calcification in hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

Klotho converts canonical FGF receptor into a specific receptor for FGF23

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

Mutation of the mouse klotho gene leads to a syndrome resembling ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

Forging forward with 10 burning questions on FGF23 in kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

Regulation of fibroblast growth factor-23 signaling by klotho

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

Removal of sialic acid involving Klotho causes cell-surface retention of TRPV5 channel via binding to galectin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

Klotho deficiency causes vascular calcification in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

Serum levels of soluble secreted α-Klotho are decreased in the early stages of chronic kidney disease, making it a probable novel biomarker for early diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

Soluble klotho and autosomal dominant polycystic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

Validation of an immunoassay for soluble Klotho protein: decreased levels in diabetes and increased levels in chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

The relationship between the soluble Klotho protein and the residual renal function among peritoneal dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

Circulating levels of soluble klotho and FGF23 in X-linked hypophosphatemia: circadian variance, effects of treatment, and relationship to parathyroid status

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

Establishment of sandwich ELISA for soluble alpha-Klotho measurement: Age-dependent change of soluble alpha-Klotho levels in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

Mineral abnormalities and long-term graft function in pediatric renal transplant recipients: a role for FGF-23?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

Investigating FGF-23 concentrations and its relationship with declining renal function in paediatric patients with pre-dialysis CKD Stages 3-5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

Vitamin D deficiency is associated with short stature and may influence blood pressure control in paediatric renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

Role of Klotho in aging, phosphate metabolism, and CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

Regulation of ion channels by secreted Klotho: mechanisms and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

Severely reduced production of klotho in human chronic renal failure kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

FGF23 fails to inhibit uremic parathyroid glands

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

Klotho and Na+,K+-ATPase activity: solving the calcium metabolism dilemma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

Randomized trial assessing the effects of ergocalciferol administration on circulating FGF23.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

Effects of vitamin D replacement therapy on serum FGF23 concentrations in vitamin D-deficient women in short term.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

Decreased serum vitamin D levels in children with asthma are associated with increased corticosteroid use

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

Vitamin D insufficiency in a large female SLE cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

Intestinal calcium absorption in exogenous hypercortisonism. Role of 25-hydroxyvitamin D and corticosteroid dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

Sevelamer hydrochloride and calcium bicarbonate reduce serum fibroblast growth factor 23 levels in dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

New equations to estimate GFR in children with CKD

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS411

21 January 2018

Identifiers

DOI

10.1093/NDT/GFS411

1 reference

1 April 2018

1 reference

1 April 2018